Diarrhea Clinical Trials in Barcelona
5 recruitingBarcelona, Spain
Showing 1–5 of 5 trials
Recruiting
Phase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection RecurrenceClostridium DifficileClostridioides Difficile Infection+7 more
Vedanta Biosciences, Inc.852 enrolled215 locationsNCT06237452
Recruiting
Phase 2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
DiarrheaIrritable Bowel Syndrome
Eli Lilly and Company531 enrolled88 locationsNCT07545759
Recruiting
Phase 3
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Carcinoid TumorCarcinoid Tumor of PancreasCarcinoid Tumor of Liver+6 more
Crinetics Pharmaceuticals Inc.141 enrolled51 locationsNCT07087054
Recruiting
Not Applicable
Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS)Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Devintec Sagl330 enrolled12 locationsNCT06681012
Recruiting
Phase 3
Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
IBS - Irritable Bowel SyndromeIBS-D (Diarrhea-predominant)IBS, Mixed Symptoms
Biocodex406 enrolled10 locationsNCT07168434